Everyday FREE SHIPPINGFedEx Ground — Continental USwith a purchase of $75 or more
Build your own list of favorite items for easy reordering
In U.S. Call: 888-803-5333 International: 001.212.665.8070
Security Seals

BCN Office Hours: 9am to 5pm Monday Through Thursday

BCN Online Store Hours: 24/7 - That's every day, all day

My Account: Sign In

Be as specific as possibe for best search results

» BCN Formulas

» A.C. Grace UNIQUE E


» Boiron Homeopathics

» FoodScience of Vermont

» Freeda Vitamins

» Herbalist & Alchemist

» Hyalogic - True HA

» Jarrow Formulas

» MushroomScience

» Labrix Services

» Longevity Science

» Pure Body Institute

» Pharmax

» RX Vitamins

» Sonne's

» Your Energy Systems



» FAMILY Nutrition

» • Women's Nutrition

» • Children's Nutrition

» • Men's Nutrition

• Senior Vitamins

» Anti-Aging

» Bone and Joint

» Calcium Formulas

» CoQ10 / QH - Ubiquinol

» Cleansing

» Detox Nutrition & Herbs

» Digestive Health

» Energy

» Heart & Cardiovascular

» Herbal Products

» Immune Support


» Magnesium

» Mind, Memory & Mood

» Natural Hormones

» Omega 3 Fish Oils

» Phytosterols

» Probiotics

» Skin Care

» Urinary Tract Support

» Vision & Eye Health

» Vitamin D3

» Weight Management


» Your Personal Best

» Iron Supplements

» Pop-Up Specials

» Hold

» Kidney Support

» Internet Only Specials

Safe, Secure,
Online Ordering with:

Safe, Secure Ordering, By QuickSSL, 128-bit SSL certificate

Beachwood Canyon,
Naturally, Ltd.

Security Seals
Certified Seal
Privacy Seals
Business Seals

Bone Dynamics 120 vegi-caps - AOR (08086)
Bone Dynamics 120 vegi-caps - AOR (08086) Quantity in Basket: None
Code: AOR-BN120

Price: $23.97


Bone Dynamics from AOR™ Advanced Orthomolecular Research
Supports Bone Structure*
Dosage: Up to 6 capsules
Size: 120 vegi-caps
Category: AOR
Product Number: 08086
Product Code: AOR-BN120

Bone Dynamics is a multi-nutrient combination designed to support bone health. It features a hydroxyapatite complex (MCHC), an extract of bovine bone derived from Australian pasture-fed, free-range livestock not subjected to routine antibiotics or rBGH.

Main Applications
As reported by literature:
• Aging
• AGE Inhibitor
• Brain Support
• Thiamin Deficiency

AOR™ guarantees that no ingredients not listed on the label have been added to the product. Contains no wheat, gluten, nuts, dairy, or eggs.

Suggested Use:
Take up to six capsules daily, dividing the dose among meals to facilitate maximum absorption, taking the largest single dose with the last meal or snack of the day, or as directed by a qualified health practitioner.

Consult a health care practitioner prior to use if you are pregnant or breastfeeding or if symptoms worsen. Consult a health care practitioner prior to use if you are taking blood thinners or if you have been diagnosed with an estrogen-dependent cancer.

Other Label Information: Keep out of the reach of children.

Supplement Facts:
Serving Size: 6 capsules
Servings Per container: 20

Amt. per Capsule % RDI
Vitamin C (Ascorbic Acid) 200 mg 333%
Calcium (from MCHC* ) 1000 mg 100%
Vitamin D3 (Cholecalciferol) 1000 IU 250%
Vitamin K2 (Menatetrenone) 120 mcg 150%
Phosphorus (from MCHC*) 455 mg 105%
Magnesium (Citrate, Oxide) 420 mg 105%
Zinc (Citrate) 11 mg 73%
Copper (Citrate) 1 mg 50%
Manganese (BisGlycinate) 5 mg 250%
Ossein Microcrystalline Hydroxyapatite Complex 4545 mg *
Boron (Citrate) 700 mcg *
Glucosamine HCL 300 mg *
% RDI Age 12 and above * Need for human nutrition not established
Other Ingredients: Hypromellose (capsule), silicon dioxide.

Vitamin D and Calcium Supplementation among Aged Residents in Nursing Homes.
J Nutr Health Aging. 2007 Sep-Oct;11(5):433-7.
Suominen MH, Hosia Randell HM, Muurinen S, Peiponen A, Routasalo P, Soini H, Suur Uski I, Pitkala KH.

Background: Aged residents in nursing homes are at particularly high risk of fractures. Vitamin D and calcium have a preventative role. Objective: To describe the use of vitamin D and calcium supplementations, and their association with nutritional factors among nursing home residents.

Methods: Our study is a cross-sectional assessment of long-term residents in all nursing homes in Helsinki during February 2003. We collected residents' background information, nutritional status (Mini Nutritional Assessment, MNA), and data on daily nursing routines in institutions, including nutritional care. Vitamin D and calcium supplementations were inquired after in the questionnaire and retrieved from residents' medication lists.

Results: 2,114 (87%) of all 2,424 eligible residents had available data on the use of vitamin D and calcium supplementation. Their mean age was 83 years, and 80.7% were female. Of all participants, 32.9% received vitamin D supplementation and 27.7% calcium supplementation. Altogether 20.0% received both. However, only 21.3% received vitamin D in the therapeutic dose of 10mg (400 IU) or more, and 3.6% in the recommended dose of 20microg (800 IU) or more. In logistic regression analysis, residents who received vitamin D supplementation also had better nutritional status (MNA), ate snacks between meals, did not have constipation and their weight was checked more frequently.

Conclusions: Regardless of the known benefit and recommendation of vitamin D supplementation for the elderly residing mostly indoors, the proportion of nursing home residents receiving vitamin D and calcium was surprisingly low.

Potential benefit of oral calcium/vitamin d administration for prevention of symptomatic hypocalcemia after total thyroidectomy.
Endocr Regul. 2007 Mar;41(1):35.
Kurukahvecioglu O, Karamercan A, Akin M, Tezel E, Ege B, Taneri F, Onuk E.

Objective: To evaluate routine oral calcium and vitamin D administration for preventing symptoms of hypocalcemia after total thyroidectomy.

Subjects and methods: A total of 487 consecutive patients were prospectively randomized into two groups in terms of routine oral calcium and vitamin D supplementation: In the control group (244 patients) the treatment was not routinely started after surgery, whereas the treated group (243 patients) received routine supplementation that started on postoperative day 1.

Results: Patients of treated group had only minor hypocalcemia symptoms, whereas 7 patients of control group experienced carpopedal spasm as a major symptom (p<0.001). None of the patients in the treated group required intravenous calcium administration. Average hospital stay of the treated group patients was significantly shorter than that of control group (p<0.001).

Conclusions: Routine postoperative calcium and vitamin D supplementation therapy may be useful for the prevention of symptomatic hypocalcemia after total thyroidectomy and may allow for a safe and early discharge from the hospital. Key words: Thyroidectomy Hypocalcemia Calcium - Vitamin D - Dietary supplementation.

Prevention of Osteoporosis: Four-Year Follow-Up of a Cohort of Postmenopausal Women Treated with an Ossein-Hydroxyapatite Compound.
Clinical Drug Investigation. 27(4):227-232, 2007.
Fernandez-Pareja A, Hernandez-Blanco E, Perez-Maceda JM, Riera Rubio VJ, Palazuelos JH, Dalmau JM.

Background: The long-term effects of ossein-hydroxyapatite compound (OHC), a drug used for osteoporosis prevention, have not been previously reported. The aim of this study was to assess the long-term efficacy of OHC in postmenopausal women with bone mineral density (BMD) in the osteopenia range.

Methods: We performed a retrospective 4-year follow-up study in a primary-care setting to assess changes in BMD in a cohort of 112 postmenopausal women included in an osteoporosis programme that included health and dietary advice and who were treated with OHC 1660mg every 12 hours. BMD was measured annually in the distal part of the forearm, with T- and Z-score values being calculated for trabecular and total bone.

Results: A progressive and statistically significant increase in BMD was observed in trabecular and total T- and Z-score mean values. At baseline, mean +/- SD trabecular T- and Z-scores were -1.27 +/- 0.7 and -1.03 +/- 0.7, respectively, and -0.86 +/- 0.7 and -0.62 +/- 0.7, respectively, at the end of the 4-year follow-up period (both p < 0.0001). Mild constipation was observed in 3.2% of patients during the follow-up period.

Conclusion: Ossein-hydroxyapatite compound could be an effective and safe agent for the prevention of bone loss in postmenopausal osteopenic women, with significant increases in BMD being observed in this group of patients.

The information and product descriptions appearing on this website are for information purposes only, and are not intended to provide medical advice to individuals. Consult with your physician if you have any health concerns, and before initiating any new diet, exercise, supplement, or other lifestyle changes. Any reproduction in whole or part and in print or electronic form without express permission is strictly forbidden. Permission to reproduce selected material may be granted by contacting AOR Inc.
Copyright © 2011, Advanced Orthomolecular Research

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.